Morad K. Nakhleh

Morad K. Nakhleh

Auto-generated profile, based on publicly available information

Morad K. Nakhleh

Univ Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Le Kremlin Bicêtre, France

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2018 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
Yoav Y BrozaYoav Y Broza
Yoav Y Broza
RVRotem Vishinkin
Rotem Vishinkin
OBOrna Barash
Orna Barash
MNMorad K. Nakhleh
Morad K. Nakhleh
HHHossam Haick
Hossam Haick
This article is an overview of the present and ongoing developments in the field of nanomaterial-based sensors for enabling fast, relatively inexpensive and minimally (or non-) invasive diagnostics of health conditions with follow-up by detecting volatile organic compounds (VOCs) excreted from one or combination of human body fluids and tissues (e.g., blood, urine, breath, skin). Part of the review provides a didactic examination of the concepts and approaches related to emerging sensing materials and transduction techniques linked with the VOC-based non-invasive medical evaluations. We also present and discuss diverse characteristics of these innovative sensors, such as their mode of operation, sensitivity, selectivity and response time, as well as the major approaches proposed for enhancing their ability as hybrid sensors to afford multidimensional sensing and information-based sensing. The other parts of the review give an updated compilation of the past and currently available VOC-based sensors for disease diagnostics. This compilation summarizes all VOCs identified in relation to sickness and sampling origin that links these data with advanced nanomaterial-based sensing technologies. Both strength and pitfalls are discussed and criticized, particularly from the perspective of the information and communication era. Further ideas regarding improvement of sensors, sensor arrays, sensing devices and the proposed workflow are also included.

26 June 2019 in European Respiratory Review
Verified
Journal Article
Open access
PDF file
RAReef Einoch Amor
Reef Einoch Amor
MNMorad K. Nakhleh
Morad K. Nakhleh
OBOrna Barash
Orna Barash
HHHossam Haick
Hossam Haick
Most of the currently used diagnostics for cancerous diseases have yet to meet the standards of screening, as they are insufficiently accurate and/or invasive and risky. In this review, we describe the rationale, the progress made to date, and the potential of analysing the exhaled volatile organic compounds as a pathway for enabling early diagnosis of cancer and, therefore, for achieving better clinical prognosis and survival rates. The review highlights the major advancements made in this field, from fundamentals, up to translational phases and clinical trials, with a special emphasis on sensing platforms based on nanomaterials. The prospects for breath analysis in early cancerous disease are presented and discussed.

14 July 2017 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
MNMk Nakhleh
Mk Nakhleh
MQM Quatredeniers
M Quatredeniers
HHHossam Haick
Hossam Haick

15 June 2022 in Journal of Breath Research
Verified
Journal Article
Closed access
JLJonathan L D Lawson
Jonathan L D Lawson
MNMorad K Nakhleh
Morad K Nakhleh
Agnieszka SmolinskaAgnieszka Smolinska
Agnieszka Smolinska
With the continued presence of COVID-19 worldwide, it has been a challenge for the breath research community to progress with clinical studies and travel restrictions have also limited the opportunities to meet up, share ideas and celebrate the latest advances. The Breath Biopsy Conference 2021 offered the chance to catch up with the latest breath research and to share progress that researchers in the community have been able to make in these difficult times. Limited opportunities for clinical research have led many in the field to look more closely at different methods for breath collection and have contributed to the growing calls for consistent standards in how results are reported, shared and even how breath studies themselves are carried out. As such, standardization was a key theme for this year’s event and featured prominently in the keynotes, discussions and throughout many of the presentations. With over 900 registrants, almost 400 live attendees and 16 speakers, the Breath Biopsy Conference continues to bring together breath research leaders from around the world. This article provides an overview of the highlights from this event.